A Look At Olema Pharmaceuticals (OLMA) Valuation After Roche Breast Cancer Trial Setback And Share Price Pullback [Yahoo! Finance]
H.C. Wainwright does not see direct read from Roche miss to Olema's OPERA-02 [Yahoo! Finance]
Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA
Olema Pharmaceuticals (OLMA) had its "buy" rating reaffirmed by TD Cowen.
Olema Pharmaceuticals (OLMA) had its price target lowered by HC Wainwright from $45.00 to $38.00. They now have a "buy" rating on the stock.